|
|
|
|
|
|
|
|
|
|
|
|
|
<TABLE> <S> <C>
<ARTICLE> 5
<CIK> 947011
<NAME> Royce Biomedical, Inc.
<MULTIPLIER> 1
<CURRENCY> U.S.
<S> <C>
<PERIOD-TYPE> 12-MOS
<FISCAL-YEAR-END> JUN-30-2000
<PERIOD-START> JUL-01-1999
<PERIOD-END> JUN-30-2000
<EXCHANGE-RATE> 1
<CASH> 137,655
<SECURITIES> 0
<RECEIVABLES> 824
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 138,992
<PP&E> 0
<DEPRECIATION> 0
<TOTAL-ASSETS> 138,992
<CURRENT-LIABILITIES> 127,476
<BONDS> 0
0
0
<COMMON> 14,296
<OTHER-SE> (40,289)
<TOTAL-LIABILITY-AND-EQUITY> 138,992
<SALES> 46,800
<TOTAL-REVENUES> 30,126
<CGS> 18,000
<TOTAL-COSTS> 189,711
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 0
<INCOME-PRETAX> (159,585)
<INCOME-TAX> 0
<INCOME-CONTINUING> (159,585)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (159,585)
<EPS-BASIC> (0.05)
<EPS-DILUTED> (0.05)
</TABLE>
|
|